•Eyedaptic launches latest version of AI-based smart glasses for AMD•Complement Therapeutics begins patient dosing in GA gene therapy trial •TED may cause reduced stromal corneal thickness•Study urges alternative tracking for wet AMD poor responders•Positive 24-month data supports the Elios System for glaucoma treatment•Eyedaptic launches latest version of AI-based smart glasses for AMD•Complement Therapeutics begins patient dosing in GA gene therapy trial •TED may cause reduced stromal corneal thickness•Study urges alternative tracking for wet AMD poor responders•Positive 24-month data supports the Elios System for glaucoma treatment
HEADLINES
FEATURED
Preclinical candidate COR1 is designed as an allogeneic source of corneal endothelial cells to replace damaged cells and restore corneal function.
Earn FREE CE 24/7 with Courses by Eyes On Eyecare
Explore premium-quality, bite-sized courses featuring leading experts like Cecelia Koetting, OD, FAAO, and Cory Lappin, OD, MS, FAAO, and continuing education covering topics from ocular rosacea treatments to retinal disease.
